Robert M Heintz

This inventor holds 56 USPTO granted patents, primarily in Retroviral Protease Inhibitors (CPC class 5441). Top assignees: G.d. Searle & Company, Monsanto Company, G.d. Searle LLC. Active years: 1988-2012.

USPTO Granted Patents = 56

% Patents Active = 69.6

Average Co-Inventor Count = 7.2

ph-index = 12

Forward Citations = 412(Granted Patents)

Forward Citations (Not Self Cited) = 266(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

26 out of 1,323

G.d. Searle & Company

Pharmacia Corporation

patents

5. 1 out of 2

Monsanto Company of St. Louis

Pharmacia Corporation (Monsanto Corporation)

patent

8. 3 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2012

Loading Chart...

Areas of Expertise:

Retroviral Protease Inhibitors

Amino Acid Sulfonamides

Cyclic Sulfone

Hydroxamic Acid Compounds

Thiol Sulfonamide

Piperidinyl Compounds

Metalloprotease Inhibitors

N-Hydroxy Compounds

Amidoaromatic Compounds

Hydroxyethylamino Sulphonamides

Aromatic Sulfonyl Compounds

Thioaryl Compounds

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE43802 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2012-11-12),

2. RE43596 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2012-08-20),

3. RE42889 - α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2011-10-31),

4. 7829564 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2010-11-09),

5. 7531538 - α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2009-05-12),

6. 7320983 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2008-01-22),

7. 7312333 - Retroviral protease inhibitors (2007-12-25),

8. 7141609 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2006-11-28),

9. 7119203 - Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors (2006-10-10),

10. 7115618 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2006-10-03),

11. 7112683 - Cyclic sulfone containing retroviral protease inhibitors (2006-09-26),

12. 7026485 - Retroviral protease inhibitors (2006-04-11),

13. 6924286 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2005-08-02),

14. 6875790 - Cyclic sulfone containing retroviral protease inhibitors (2005-04-05),

15. 6846954 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2005-01-25),

Title: The Innovative Journey of Robert M Heintz

Introduction: Robert M Heintz, a talented inventor hailing from Ballwin, Missouri, has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Robert M Heintz holds several patents in various fields, showcasing his versatility and ingenuity in inventing new solutions to everyday challenges.

Career Highlights: Throughout his career, Robert M Heintz has demonstrated a keen ability to identify gaps in the market and develop groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of several successful products that have improved the lives of many.

Collaborations: Robert M Heintz has collaborated with leading experts in the industry, leveraging their knowledge and expertise to bring his inventions to life. His collaborative spirit has enabled him to achieve greater heights in the world of innovation.

Conclusion: Robert M Heintz's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the field of inventing. His contributions have left a lasting impact on the world of technology and beyond.